Ra Medical Systems, which develops excimer lasers used to treat dermatologic and cardiovascular diseases, filed on Monday with the SEC to raise up to $86 million in an initial public offering.
The Carlsbad, CA-based company was founded in 2002 and booked $6 million in revenue for the 12 months ended March 31, 2018. It plans to list on the NYSE under the symbol RMED. Ra Medical Systems filed confidentially on May 21, 2018. Piper Jaffray and Cantor Fitzgerald are the joint bookrunners on the deal. No pricing terms were disclosed.
